Page last updated: 2024-09-03

omega-n-methylarginine and Diabetic Neuropathies

omega-n-methylarginine has been researched along with Diabetic Neuropathies in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, SR; Pan, HL1

Other Studies

1 other study(ies) available for omega-n-methylarginine and Diabetic Neuropathies

ArticleYear
Spinal nitric oxide contributes to the analgesic effect of intrathecal [d-pen2,d-pen5]-enkephalin in normal and diabetic rats.
    Anesthesiology, 2003, Volume: 98, Issue:1

    Topics: Analgesics, Opioid; Animals; Behavior, Animal; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Enkephalin, D-Penicillamine (2,5)-; Enzyme Inhibitors; Injections, Spinal; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; omega-N-Methylarginine; Pain; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley

2003